Rhea Coler | Biomedical Sciences | Best Researcher Award

Research Excellence Award

Rhea Coler
Affiliation Seattle Children’s Research Institute
Country United States
Scopus ID 7004227435
Documents 165
Citations 12,421
h-index 54
Subject Area Biomedical Sciences
Event The Scientist Global Awards

The Best Researcher Award recognizes research contributions, scholarly productivity, scientific influence, and sustained engagement with the advancement of knowledge. This academic recognition profile presents the supplied bibliometric information for Rhea Coler, affiliated with Seattle Children’s Research Institute in the United States, within the field of biomedical sciences. The profile is intended to provide an organized overview of research activity and its relevance to scientific recognition through The Scientist Global Awards.[1]

Abstract

This article documents a researcher profile prepared in the context of the Best Researcher Award presented through The Scientist Global Awards. The supplied information identifies Rhea Coler as a researcher affiliated with Seattle Children’s Research Institute in the United States, with a subject-area classification of biomedical sciences. The provided bibliometric indicators report 165 documents, 12,421 citations, and an h-index of 54. These measures offer a quantitative starting point for describing scholarly output and citation activity, but they do not independently establish research quality, individual contribution, or eligibility for an award.  [1]

Keywords

Best Researcher Award; Rhea Coler; biomedical sciences; research evaluation; bibliometrics; scientific publications; citation analysis; h-index; scholarly impact; Seattle Children’s Research Institute; The Scientist Global Awards.

Introduction

The Best Researcher Award profile for Rhea Coler brings together the researcher details and bibliometric figures supplied for this article. The profile identifies Seattle Children’s Research Institute as the stated institutional affiliation and biomedical sciences as the subject area. The linked Scopus record provides a starting point for independent verification of the author identifier and publication information. [1]

Research Profile

The supplied profile places Rhea Coler within biomedical sciences and identifies Seattle Children’s Research Institute in the United States as the institutional affiliation. Biomedical sciences encompass a broad range of research areas concerned with biological systems, human health, disease mechanisms, and the development of scientific approaches to health-related questions. A detailed description of a researcher’s particular specialization requires verification through publications, institutional information, and relevant scholarly records. [1]

Research Contributions

Evaluating research contributions in biomedical sciences requires consideration of the questions investigated, the reliability of the methods used, the originality of the findings, and the extent to which results advance knowledge. Research contributions may include original investigations, collaborative studies, methodological developments, evidence synthesis, and the development of resources that support subsequent scientific work. [2]

Publications

The supplied bibliometric information reports 165 documents associated with the Scopus author identifier 7004227435. This figure is presented as provided and has not been independently checked against a live database snapshot. A publication-level assessment should confirm the author’s identity across records and distinguish research articles from reviews, conference papers, and other document types where relevant. Citation patterns can provide additional context, but citation counts alone do not establish the validity or importance of an individual paper. [1] [2]

Research Impact

The reported total of 12,421 citations and h-index of 54 provides a quantitative description of the scholarly attention associated with the supplied author profile. Citation indicators can help identify patterns of scholarly engagement, locate influential publications, and compare research activity when appropriate disciplinary and career-stage context is available. However, citation databases vary in their coverage, and citation totals may include different document types and reflect multiple reasons for referencing a publication. [1]

Award Suitability

The Best Researcher Award recognizes scholarly achievement and provides a framework for reviewing research productivity, scientific contribution, and professional impact. The information supplied for Rhea Coler includes a stated institutional affiliation, a biomedical sciences subject classification, and three bibliometric indicators. These details may serve as inputs to an award assessment, subject to verification and the eligibility and evaluation criteria established by the organizing body. [3]

Conclusion

This academic recognition profile summarizes the supplied information for Rhea Coler, identified with Seattle Children’s Research Institute in the United States and the subject area of biomedical sciences. The reported record includes 165 documents, 12,421 citations, and an h-index of 54. These indicators offer a useful starting point for understanding publication activity and scholarly engagement, but they require appropriate context and verification. [1]

References

  1. Elsevier. (2026). Scopus author details: Rhea Coler, Author ID 7004227435. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7004227435
  2. Schistosomiasis vaccine SchistoShield® induces functional immune memory responses in US and African populations.
    https://doi.org/10.1038/s41541-026-01501-0
  3. The Scientist Global Awards. (2026). Official award website.
    https://thescientists.net/

Adam Singer | Biomedical Sciences | Best Researcher Award

Best Researcher Award

Adam Singer
Stony Brook University, United States

Adam Singer
Affiliation Stony Brook University
Country United States
Scopus ID 7202643682
Documents 463
Citations 22,404
h-index 64
Subject Area Biomedical Sciences
Event The Scientist Global Awards
ORCID 0000-0003-4694-6152

Adam Singer is a biomedical scientist affiliated with Stony Brook University whose scholarly work encompasses translational medicine, critical care, infectious diseases, and related biomedical research. His publication record, citation impact, and sustained contributions to the scientific literature demonstrate long-term engagement with evidence-based clinical investigation and interdisciplinary collaboration. According to the Scopus database, his research output includes hundreds of indexed publications with substantial international citation impact, reflecting continued influence within the biomedical sciences community.[1]

Abstract

This article summarizes the academic profile of Adam Singer in relation to recognition for the Best Researcher Award. The profile highlights measurable scholarly indicators, institutional affiliation, publication productivity, citation performance, and sustained research engagement within biomedical sciences. The overview follows a neutral encyclopedic style and is intended to provide a concise academic summary based on publicly available scholarly information.[1]

Keywords

Biomedical Sciences, Clinical Research, Critical Care Medicine, Evidence-Based Medicine, Research Impact, Scientific Publications

Introduction

Biomedical sciences integrate laboratory discoveries with clinical applications to improve diagnosis, treatment, and patient outcomes. Researchers with sustained publication activity contribute to advancing scientific knowledge through rigorous investigation, peer-reviewed dissemination, and collaborative research initiatives. Adam Singer’s scholarly record reflects continued participation in these objectives through extensive publication and citation performance documented in international indexing services.[1]

Research Profile

Adam Singer has established a substantial academic profile supported by 463 Scopus-indexed publications, more than 22,000 citations, and an h-index of 64. These bibliometric indicators demonstrate consistent scholarly productivity together with broad visibility within biomedical research. His affiliation with Stony Brook University reflects active participation in a major research institution recognized for clinical and translational investigation.[1]

Research Contributions

The research contributions associated with Adam Singer include investigations that support evidence-based clinical practice, emergency medicine, critical care, infectious diseases, and multidisciplinary biomedical research. His publications have contributed to scientific understanding through collaborative studies, methodological rigor, and dissemination in peer-reviewed journals indexed by international databases.[2]

Publications

The publication portfolio demonstrates continuous scholarly activity across multiple biomedical disciplines. Numerous articles have appeared in internationally recognized journals, contributing to advancements in clinical medicine, patient care, biomedical methodology, and translational health research. Citation performance indicates that these publications continue to inform subsequent scientific investigations.[1][2]

Research Impact

Research impact may be assessed through citation metrics, publication quality, collaborative engagement, and influence on future investigations. Adam Singer’s extensive citation record together with a high h-index illustrates sustained scholarly recognition within the biomedical sciences community. These indicators are commonly used to evaluate scientific influence while complementing qualitative assessment of research significance.[1]

Award Suitability

Based on publicly available academic indicators, Adam Singer demonstrates characteristics generally associated with recognition for research excellence, including sustained publication productivity, international citation impact, interdisciplinary collaboration, and long-term contribution to biomedical science. Consideration for the Best Researcher Award would appropriately incorporate peer evaluation, scientific originality, publication quality, institutional contributions, and measurable research influence.[1]

Conclusion

Adam Singer’s academic record reflects an established career characterized by extensive scholarly output, international visibility, and measurable research impact within biomedical sciences. His publication history, citation performance, and institutional affiliation collectively represent a strong example of sustained scientific engagement and provide an objective foundation for academic recognition within international research award programs.[1]

References

  1. Elsevier. (2026). Scopus author details: Adam Singer, Author ID 7202643682. Scopus.
    https://www.scopus.com/pages/authors/7202643682
  2. Journal of Surgical Research. (2026). A Simple Risk Assessment Tool for Older Adult Trauma Patients—Silver Trauma Score.
    https://doi.org/10.1016/j.jss.2026.06.011
  3. The Scientist Global Awards. International Scientific Recognition Program.
    https://thescientists.net/

Al-Zahraa Khalifa | Pharmaceutical Sciences | Research Excellence Award

Assist. Prof. Dr. Al-Zahraa Khalifa | Pharmaceutical Sciences | Research Excellence Award

Assistant Professor | Dubai Medical University | United Arab Emirates

Dr. Al Zahraa Mahmoud Khalifa is an emerging researcher in pharmaceutical sciences with expertise in advanced drug delivery systems, vaccine adjuvants, nano-formulations, and pharmaceutical product development. Her research focuses on the design and optimization of innovative delivery platforms including liposomes, niosomes, emulsions, and multi-modal vaccine delivery systems to improve therapeutic efficacy and patient outcomes. She has contributed significantly to the advancement of pharmaceutics through her scholarly work in formulation science, nanotechnology-based drug carriers, and subunit antigen delivery strategies. Dr. Khalifa has authored 6 research documents, accumulating 94 citations with an h-index of 4, reflecting her growing academic influence in pharmaceutical and biomedical research. Her publications appear in reputable international journals, particularly in the areas of pharmaceutics, drug delivery, and vaccine technology. With a strong commitment to translational pharmaceutical research, Dr. Al Zahraa Mahmoud Khalifa continues to contribute to the development of next-generation therapeutic and vaccine delivery technologies.

Citation Metrics (Scopus)

100

75

50

25

0

 

94
Citations

6
Documents

4
h-index

Citations

Documents

h-index

Featured Publications